Objective: Research has focused on 2 different approaches to answering the question, "Which clients will respond to cognitive behavioral therapy (CBT) for depression?" One approach focuses on rates of symptom change within the 1st few weeks of treatment, whereas the 2nd approach looks to pretreatment client variables (e.g., hopelessness) to identify clients who are more or less likely to respond. The current study simultaneously examines these 2 lines of research (i.e., early symptom change and pretreatment variables) on the prediction of treatment outcome to determine the incremental utility of each potential predictor. Method: The sample consists of 173 clients (66.47% female, 92.49% Caucasian), 18 -64 years of age (M ϭ 27.94, SD ϭ 11.42), receiving treatment for depression and anxiety disorders in a CBT-oriented psychology training clinic. Results: The rate of change in depressive symptom severity from baseline over the 1st 5 treatment sessions significantly predicted treatment outcome. A contemplative orientation to change and medication status positively predicted early symptom change, whereas student status negatively predicted early symptom change. Higher levels of baseline anxiety, precontemplative readiness to change, and global functioning predicted lower levels of depressive symptom severity at termination. Conclusions: The findings suggest achieving rapid symptom change early in treatment may be integral to overall success. As such, therapists may wish to target factors such as readiness to change to potentially maximize rapid rate of symptom change and subsequent treatment outcome.
Over 325 cognitive behavioral therapy (CBT) outcome studies reveal large effects for treating adult depression, panic disorder, generalized anxiety disorder, social phobia, and posttraumatic stress disorder (Butler, Chapman, Forman, & Beck, 2006) . However, a closer look at the literature suggests that response rates are actually quite variable, ranging from as low as 40% for depression (DeRubeis et al., 2005) to as high as 90% for panic disorder (Clark et al., 1994) . Inconsistent rates of response to CBT targeting the same disorder have been observed even when the same treatment protocol is used. Two studies using the same social phobia group treatment protocol reported response rates of 75% (Heimberg et al., 1990) and 36% (Hope, Heimberg, & Bruch, 1995) , respectively, even though no obvious differences between the studies-in terms of sample characteristics, therapist experience, or outcome measure-were observed.
These very different response rates to the same treatment protocol highlight that although CBT has been identified as an empirically supported treatment, it is not effective for all clients. This is certainly not a new observation. Four decades ago, Gordon Paul (1967, p. 111) articulated the question, "What treatment, by whom, is most effective for this individual with that specific problem, under which set of circumstances?" This question guided psychotherapy research in the search for predictors and moderators of response, but it has not yet yielded robust results. Clinical variables such as comorbidity have emerged as predictors in some studies (e.g., Green et al., 2006) but not others (e.g., Kuyken & Tsivrikos, 2009) . Cognitive variables such as readiness to change have recently predicted treatment outcome, at least with depressed adolescents (e.g., Lewis et al., 2009 ), but their predictive utility warrants further investigation. Finally, the effect of contextual variables (e.g., age, gender) on treatment outcome has been similarly equivocal. Because the findings on these predictors are not consistently observed, they provide limited utility for clinicians to guide their treatment planning.
It may be that rather than simply focusing on the relation between pretreatment factors and post-treatment symptom scores, analysis of symptom change over time may provide important additive information. Such an approach might be necessary to unpack the variable findings reported above. In fact, this line of research appears to be a fruitful endeavor. Ilardi and Craighead (1994) observed that 60%-80% of improvement in depressive symptoms occurred within the first four weeks of CBT, which, in turn, predicted outcome. Numerous other studies similarly observed rapid depressive symptom improvement as a predictor of outcome upon reanalysis of the data (e.g., Beckham, 1989; Fennell & Teasdale, 1987) . There is growing evidence that the predictive validity of rapid early response in psychotherapy may be an important process in understanding treatment outcomes.
It therefore is important to examine both pretreatment factors and rate of early symptom change simultaneously to determine their respective contributions to the prediction of outcome. Only two studies, to our knowledge, have simultaneously examined the role of pretreatment variables and trajectories of change to determine predictors of long-term outcomes and, specifically, relapse at follow-up. Santor and Segal (2001) found rates of change in the first 10 weeks negatively predicted symptoms at 3 months over and above initial severity and rates of later change. Similarly, Gilboa-Schechtman and Shahar (2006) found that rates of change in the first 4 weeks of therapy positively predicted outcome at 12-and 18-months post-treatment over and above initial severity and remoralizer status (slow or rapid dichotomization of distress relief within the first 4 weeks of treatment). Interestingly, a significant relation between rapid depressive symptom reduction and psychotherapy outcome was not observed in non-psychological (psychopharmacology, placebo with clinical management) therapies (Gilboa-Schechtman & Shahar, 2006) . Although these studies were important contributions to the literature, they only examined a limited number of pretreatment factors in the prediction of long-term outcomes.
The present study sought to extend prior work by examining both trajectories of early symptom change using latent growth curve modeling and pretreatment factors in a naturalistic course of CBT conducted in a specialty clinic. Specifically, both rate of early symptom change and a more extensive set of pretreatment variables were examined with the aim to determine the incremental utility of these factors in terms of achieving lower depressive severity at termination. The following pretreatment variables were included in the analyses because they had been previously identified as significant predictors of treatment outcome: (1) clinical variables: comorbidity, depressive symptom severity, anxiety symptom severity, and global functioning; (2) cognitive variables: hopelessness, readiness to change (i.e., four subscales: Precontemplation, Contemplation, Action, Maintenance), and dysfunctional attitudes; and (3) contextual variables: age, gender, student status, and medication status. It was hypothesized that rapid response would be a robust predictor of treatment outcome demonstrating incremental predictive utility over and above the aforementioned 14 pretreatment factors. The second aim was to examine the extent to which pretreatment factors such as readiness to change predicted trajectories of early symptom change. Due to the limited research in this area, no a priori hypotheses were specified; rather, Aim 2 was exploratory in nature.
Method Participants
Participants were predominantly Caucasian (92.49%; comparable to the demographic makeup of the community from which the sample was drawn) adults ranging in age from 18 to 64 years (M ϭ 27.94, SD ϭ 11.42) who voluntarily presented for therapy in a university training clinic. The majority of clients were referred by the University Counseling and Testing Center, with a small proportion of clients referred by community practitioners and family. Clients were students (65.90%) and community members (34.10%); two thirds were female (66.47%). Of the 269 clients who sought treatment, 236 completed an intake, and 14 were referred elsewhere, resulting in 222 clients receiving services in the clinic. Forty-three of the 222 clients endorsed only minimal depressive symptom severity at baseline and thus were excluded from the analyses, leaving 173 clients in the current study analysis sample.
Nearly 8% of clients either did not meet criteria for an Axis I disorder or had their diagnosis deferred (n ϭ 14), 30.06% met criteria for a single diagnosis (n ϭ 52), and 61.85% met criteria for comorbid diagnoses (n ϭ 107). The most common primary diagnosis was major depressive disorder (MDD), recurrent, moderate (n ϭ 36), followed by generalized anxiety disorder (n ϭ 20) and social phobia (n ϭ 13). Depressive diagnoses (including variants of MDD, adjustment disorder with depressed mood, and dysthymic disorder) composed 56.07% (n ϭ 97) of the primary diagnoses, and 32% of clients (n ϭ 55) had a primary anxiety disorder (e.g., generalized anxiety disorder, social phobia, posttraumatic stress disorder), with the remaining 12% of diagnoses broken up over diverse categories (e.g., dissociative disorder, bipolar) at baseline.
Procedures
The initial stage of the assessment included a standardized phone screen completed by a master's-level clinic coordinator to obtain the following information: age, referral source, medication usage, suicidality, counseling history, and presenting problems. Because this clinic did not offer 24-hr crisis support, clients with active suicidality, psychosis, and drug or alcohol dependence were referred to a community agency equipped with crisis-ready resources.
Measures
The Semi-Structured Clinical Interview for the DSM-IV (SCID-I; First, Spitzer, Gibbon, & Williams, 1997) was administered by master's-level therapists in their 1st-6th year of practicum to assess for Axis I disorders. Therapists received several weeks of focused SCID-I training that included observing live interviews conducted by experienced therapists, role play practice with feedback, and careful supervision with ongoing administration. The following compose the standard baseline battery of measures.
The Beck Depression Inventory (BDI; Beck, Ward, Mendelsohn, Mock, & Erlbaugh, 1961 ) is a 21-item self-report measure used to assess severity of depressive symptoms. Each item was scored on a 0 -3 scale to reflect the absence or degree of the symptom. Cronbach alphas from the present sample demonstrated strong internal reliability over time (ranging from .88 to .92). The total score (ranging from 0 to 63; higher scores indicate greater severity) served as the primary outcome measure. Clients completed BDIs at each session. The final observation served as the "termination" BDI score and was not included in the rate of early symptom change.
The Beck Anxiety Inventory (BAI; Beck & Steer, 1993 ) is a 21-item self-report measure used to assess severity of anxiety symptoms. Each item is scored on a 0 -3 scale to reflect the absence or degree of the symptom. Cronbach alphas from the present sample demonstrated strong internal reliability over time (ranging from .89 to .92). Total scores ranged from 0 to 63; higher scores indicate greater severity. Initial BAI scores were controlled for, given the literature demonstrating its close association with depression (e.g., Beck, Epstein, Brown, & Steer, 1988) .
The Stages of Change Schedule (SOCS; McConnaughy, Prochaska, & Velicer, 1983 ) is a 32-item self-report measure to assess readiness to change. Eight items correspond to each of the four subscales: Precontemplation, Contemplation, Action, and Maintenance. Response options include a Likert scale ranging from 0 (strongly disagree) to 5 (strongly agree). The SOCS demonstrated adequate internal consistency in the present sample (␣ ϭ .82). Four separate readiness to change scores were derived through simple summing of subscale items (see Lewis et al., 2009) .
The Dysfunctional Attitudes Scale (DAS; Weissman & Beck, 1978 ) is a 40-item self-report scale that measures patterns of maladaptive thinking thought to constitute a cognitive diathesis to depression. A Likert scale ranging from 1 (totally disagree) to 7 (totally agree) is used to respond to each item. Higher scores indicate more dysfunctional attitudes. The DAS demonstrated strong internal consistency in this sample (␣ ϭ .92).
The Beck Hopelessness Scale (BHS; Beck, Weissman, Lester, & Trexler, 1974 ) is a 20-item true/false self-report measure of pessimism; higher scores indicate greater hopelessness. The psychometric properties in the current sample suggest strong internal consistency (␣ ϭ .88).
The Global Assessment of Functioning (GAF; Spitzer, Gibbon, Williams, & Endicott, 1996 ) is a scale used by therapists to rate the social, occupational, and psychological functioning of the client from 1 to 100. Higher scores indicate greater functioning. Psychometric properties suggest moderate reliability (Cronbach ␣ ϭ .74; Hilsenroth, Ackerman, & Blagys, 2000) .
Comorbidity. Clients were assigned to one of three comorbidity groups based on the number of baseline diagnoses: (1) no/deferred diagnosis, (2) single disorder, and (3) comorbid disorders. Comorbidity was controlled for in subsequent analyses.
Medication status. Prior to treatment, clients were asked whether they were already taking psychotropic medication to treat their condition; responses were coded "yes" or "no." Medication status was controlled for in subsequent analyses.
Reliable change index (RCI).
The formula put forth by Jacobson and Truax (1991) for clinically significant change as per the RCI was used to classify responders and non-responders. Responder status was assigned to those whose RCI was greater than 1.96. The termination session in the formula refers to the last occurring therapy session. No prescribed number of sessions was identified given the naturalistic nature of this study.
Therapists
Therapists were clinical psychology doctoral students enrolled in practicum. Thirty-three therapists in their 2nd-6th year of the doctoral program had an average of 14.08 (SD ϭ 10.09) months of CBT training at the initial session with the client. Therapists were predominantly female (90.04%). Therapist level of training was measured in months since entering practicum. Therapists' previous and additional experiences were not collected. Training consisted of weekly didactics and role play in addition to supervision. In their first year of practicum, therapists typically began working with a single disorder case and would later reach a maximum of four more complex cases. Therapist level of training was controlled for in subsequent analyses because client complexity was matched to therapist level of training.
Treatment
General approach. Treatment was CBT with considerable flexibility in terms of focus and number of sessions compared to CBT as delivered in randomized controlled trials (RCTs). A strong emphasis was placed on case conceptualization. Approximately 15% of therapists received additional training in CBT variants such as acceptance and commitment therapy. Neither therapist competency nor fidelity to treatment was systematically measured.
Specific interventions.
The first therapist-client meeting served as a comprehensive intake session in which the SCID-I was administered. Therapists approached the intake as an information gathering session to not only deem whether the services provided at the clinic would be optimal for the client's presenting problems (if not, the client was referred to a more suitable match at a community agency) but also to identify therapist match for ongoing treatment.
The second meeting with the client served as a feedback session in which the results of the SCID-I and the assessment battery were reviewed. The therapist and client collaborated to develop a problem and goal list. The CBT model was introduced using a collaboratively identified example to set the stage for ongoing treatment. CBT-based psychoeducation regarding the client's presenting problem and approach to treatment was provided verbally and often in paper form (drawing from handouts available from Leahy & Holland's, 2000, workbook) to be read for homework. The third meeting typically reviewed and continued with psychoeducation with the introduction of additional interventions based upon the most recent evidence-based CBT protocols available and delivered flexibly. Clients with depression were treated according to Beck's (1979) Cognitive Therapy of Depression and incorporated behavioral activation as articulated in Addis and Martell (2004) . Depending on the presenting problem and associated protocol/ treatment plan, by the end of the fifth session clients likely (1) had been monitoring activities and had begun activity scheduling and behavioral activation for depression, (2) had built an exposure hierarchy for anxiety disorders, and (3) had an introduction to cognitive restructuring.
CBT structure was embedded within each session and included agenda setting, a mood check, session bridging, review of homework, introduction to a new skill applied to a client problem, collaboration and assignment of homework, followed by a summary and feedback. Therapists used guided discovery and capsule summaries throughout. Clients who did not complete their homework between sessions were assisted by the therapist to complete the assignment within session and to troubleshoot ways to complete future assignments.
Data Analytic Plan and Statistical Analyses
Baseline analyses were run using SAS Version 9.1. Analytic
Step 1 consisted of baseline analyses to characterize the sample according to clinical, cognitive, and contextual variables. General linear models (GLMs) were used to compare comorbidity groups on depressive and anxiety symptom severity. Student t tests were conducted to examine whether depressive and anxiety symptom severity differed across dichotomous variables such as medication status. Bivariate Pearson product-moment and point-biserial correlations were run to examine the relation between baseline clinical, cognitive, and contextual variables.
Analytic
Step 2 involved latent growth curve modeling (LGCM) to identify the early response trajectory of depressive symptoms from intake over the first five sessions using Mplus 5.1 (Muthén & Muthén, 2007) . As noted above, therapist level of training, medication status, and comorbidity status were included in the model as control variables. The full information maximum likelihood algorithm was employed to handle missing data in all analyses. This approach allows modeling incomplete data (Enders & Bandalos, 2001 ). Complete BDI data across all time points were available on 114 (65.9%) clients.
Step 3 included all of the hypothesized predictors to examine the extent to which these variables predicted variability observed in initial status and growth rate of depressive symptom severity over time. Pretreatment factors (i.e., therapist level of training, medication status, comorbidity, depressive and anxiety severity, gender, age, student status, global functioning, hopelessness, stages of change, and dysfunctional attitudes) were added to the best-fit model described above.
Step 4 regressed outcomes on both latent growth factors (the initial status and growth rate) of early response trajectories of depressive symptoms and pretreatment factors (clinical, cognitive, and contextual variables) to examine the incremental utility of these two aspects in predicting treatment outcome.
Results

Baseline Analyses
Baseline demographics. Approximately 36% of clients endorsed suicidal ideation, and 44.05% reported taking medication when queried by the clinic coordinator during the phone screen. Moderate depressive (BDI: M ϭ 20.08, SD ϭ 7.43) and anxiety (BAI: M ϭ 14.05, SD ϭ 8.15) symptom severity characterized symptomatology at intake. GAF scores (M ϭ 59.34, SD ϭ 9.65) suggested moderate impairment in participants. The average level of hopelessness (M ϭ 7.89, SD ϭ 4.91) was slightly below the clinical cutoff of 9. The highest subscale score of the SOCS indicated that the sample, on average, could be characterized as contemplative (M ϭ 4.49, SD ϭ 0.41), suggesting that clients were aware of a distressing life situation but were not yet ready to fully take action toward change.
Baseline correlational analyses. Depressive symptom severity was moderately positively correlated with anxiety symptom severity. Small, but significant, positive correlations were observed between depressive symptom severity and the following: contemplation stage of change, age, medication status, comorbidity status, and therapist level of training. Depressive symptom severity was moderately negatively correlated with global functioning. Moderate positive correlations were observed between the following SOCS subscales: Contemplation, Action, and Maintenance. See Table 1 for a complete listing of baseline bivariate correlations.
Characterization of depressive symptom severity. Sample means from baseline and the first five treatment sessions were plotted to examine the symptom trajectory and were used to guide subsequent modeling (see Figure 1) . Review of the data suggested that depressive symptom scores followed a roughly linear trajectory indicating that a strict linear slope would serve as an appropriate baseline model for comparison. Each of the BDI scores from 
Trajectories of Early Response
LGCM was employed in order to characterize the trajectories of client response to treatment across baseline and the first five treatment sessions. A series of a priori specified growth models were examined to identify the best-fitting and most parsimonious model characterizing the initial status and change in depressive symptoms from baseline and over the first five treatment sessions. The first step specified a two factor linear growth model in which the mean and variance of both the intercept (i.e., initial status) and slope (i.e., rate of change over time) factors were allowed to randomly vary within the person (Muthén & Muthén, 2007) . If fit was less than adequate, then linear spline models were estimated, and finally, a quadratic growth factor was included. Linear spline models accommodate potential nonlinearity while keeping the growth model relatively parsimonious (Stoolmiller, 1995) . In the current application, intercept loadings were fixed to one, and the first two loadings for the slope factor were constrained to zero and one, respectively, with the remaining loadings free to be estimated. Linear spline models allow for flexibility in the linear trajectory by modeling piecewise curves or crooked lines in which the line segments do not necessarily map onto the overall straight line while testing the assumption that a linear trend is the most accurate characterization of the scores. Linear spline models account for both shape (i.e., nonlinear) and direction (i.e., trend upward or downward) within the growth rate factor estimate given the flexibility described above (see Stoolmiller, 1995 , for more technical details). The growth factors were regressed on the following covariates in all modeling estimates: therapist level of training, medication status, and comorbidity status.
The strict linear and quadratic models were rejected, as they fit the data poorly. However, the linear spline model in which the residual covariances of the BDI scores were constrained to be equal across time was chosen, as it was the most parsimonious with fit statistics in the desired range: 2 (23) ϭ 29.54, p ϭ .16; comparative fit index (CFI) ϭ .99; root-mean-square error of approximation (RMSEA) ϭ .04 (see Figure 2 for a graphical representation). The model suggests that, on average, the depressive symptom trajectories began at a moderate severity (intercept z ϭ 2.28) and fairly rapidly decreased across baseline and the first five treatment sessions (slope z ϭ Ϫ1.68). Significant variability was observed in both initial status and growth rate. The nonsignificant result of the covariance between the intercept and slope suggests that the client's initial status of depressive symptom severity has little influence on the rate or direction of change. Psychotropic use and comorbidity were significantly positively associated with the intercept factor, whereas level of therapist training was not statistically significant. Only baseline medication status predicted rate of change in BDI symptoms: Concomitant psychotropic use was related to an accelerated decrease in depressive symptomatology.
Pretreatment Predictors of Trajectories of Early Symptom Change
Next, we examined to what extent pretreatment variables explained variability in the initial status (intercept) and growth rate (slope) of depressive symptomatology. Fourteen pretreatment variables from three categories were added to the model: (1) clinical variables: comorbidity, depressive symptom severity, anxiety symptom severity, and global functioning; (2) cognitive variables: hopelessness, readiness to change (i.e., four subscales: Precontemplation, Contemplation, Action, Maintenance), and dysfunctional attitudes; and (3) contextual variables: age, gender, student status, and medication status. The model continued to fit the data well, as evidenced by fit statistics in the desired range, 2 (67) ϭ 68.42, p ϭ .43; CFI ϭ .99; RMSEA ϭ .01.
The initial status of early response trajectories of depressive symptoms was significantly predicted by concomitant psychotropic usage, anxiety symptom severity, student status, hopelessness, and a contemplative orientation to change (see Table 2 ). Concomitant psychotropic usage, student status, and a contemplative orientation to change were identified as significant predictors of an accelerated decline in depressive symptomatology.
Predictors of Outcome: Trajectories of Change and Pretreatment Factors
Analytic Step 4 was designed to answer the question, "Does initial symptom severity or rate of change across the first five treatment sessions predict outcome?" In addition, the inclusion of previously identified predictors of response regressed on the same distal outcomes would provide information regarding the incremental utility of these factors.
BDI total score at termination was regressed on the intercept and slope of the best-fitting baseline growth model. Number of sessions was also controlled for in all outcome analyses. Based on the results from Analytic Step 4, anxiety symptom severity, student status, hopelessness, and contemplation scores were regressed on the intercept, whereas only student status and contemplation scores were regressed on the slope. To examine the incremental utility of trajectories of early symptom change and pretreatment variables as predictors of outcome, all factors were included simultaneously.
This model fit the data well, explaining 52.4% of the variance, 2 (92) ϭ 106.09, p ϭ .15; CFI ϭ .98; RMSEA ϭ .03. Both intercept (␤ ϭ 0.77, SE ϭ 0.19, p Ͻ .001) and slope (␤ ϭ 1.19, SE ϭ 0.38, p Ͻ .001) predicted treatment outcome: Greater intake depressive symptom severity and an accelerated growth rate predicted lower BDI scores at termination. Greater intake anxiety symptom severity (␤ ϭ -0.17, SE ϭ 0.05, p Ͻ .01), higher baseline global functioning (␤ ϭ -0.19, SE ϭ 0.08, p Ͻ .01), and precontemplation scores (␤ ϭ -2.87, SE ϭ 1.42, p Ͻ .05) predicted lower BDI scores at termination. No other pretreatment variables predicted treatment outcome. 
Discussion
The overarching goal of this study was to examine the incremental utility of trajectories of early symptom change simultaneously with pretreatment factors in predicting treatment outcome. In support of our hypothesis, the rate of change in BDI scoresacross baseline and the first five sessions-predicted BDI scores at termination explaining 52.4% of the variability in response to treatment. That rates of early depressive symptom change predicted outcome reaffirms its role as a robust predictor even when controlling for number of sessions and examining the effect of 14 other pretreatment factors previously identified as predictors of outcome. Two other studies similarly reported the observed incremental predictive utility of rates of early symptom change with respect to symptom return at 3-, 12-, and 18-months posttermination (Gilboa-Schechtman & Shahar, 2006; Santor & Segal, 2001) . Our study adds to this developing literature that early rate of depressive symptom change predicts to acute outcomes and that its predictive utility is observed even when compared to 14 previously identified pretreatment predictors of outcome. It is important to note that while a large amount of total symptom reduction was observed after the intake session (76%), this rate of change did 1 In order to confirm the incremental predictive utility of the rate of early symptom change after the fifth session, two additional analyses were run to investigate whether the rate of change after the (1) intake and (2) 10th session predicted outcome. Both sets of analyses revealed that the slopes were not significant predictors of outcome. Additional details regarding these analyses are available from the corresponding author. not significantly predict outcome when compared to the rapid rate of response achieved by the end of the fifth session, at which point 85.47% of total symptom change was observed.
Pretreatment Predictors
The second aim of this study was to examine the extent to which pretreatment factors predicted rapid early symptom change. Identification of predictors of early symptom change might provide clinicians with helpful information for tailoring treatment. Perhaps surprisingly, the LGCM revealed no significant correlation between intercept and slope. Few studies have reported on this relation despite its relevance to understanding the process by which symptoms change over the course of therapy. However, Santor and Segal (2001) similarly reported that pretreatment depressive symptom severity was not significantly related to rate of early symptom change, suggesting that rapid early symptom reduction is equally achievable regardless of initial severity and that other pretreatment variables might be more important for therapists to consider.
A unique feature of the current study's sample revealed itself as a predictor of response rate. That is, the sample contained a mix of both students and community members, two subpopulations presenting for therapy. Student status (specifically clients who were students) was associated with lower depressive symptom severity at intake and decelerated rates of early depressive symptom change. It is possible that students with less severe depression presented for treatment because it was free to them, whereas community members were required to pay. In terms of early symptom change, it may be that community members were much more committed to treatment, which manifested in greater homework completion-a key ingredient to achieving successful response to CBT (e.g., Bryant, Simons, & Thase, 1999; Simons, Marti, Rohde, Lewis, & March, 2012) . Alternatively, it might be that community members had greater expectancy that CBT would be effective given the likelihood that they sought out services at this particular clinic because of its strong reputation for CBT. This interpretation would also be supported by the literature suggesting that expectancy is significantly related to outcome (Curry et al., 2006) .
There is a dearth of research examining the role of readiness to change on treatment outcome, much less on its relation to early symptom change. Recently, however, having an action orientation has been identified as a predictor and mediator of treatment for adolescent depression (Lewis et al., 2009 ). In the present study, higher contemplation scores predicted an accelerated rate of change in depressive symptomatology. This is in accord with Lichtenberg and Hummel's (2000) work with a similarly depressed and anxious adult sample, the difference being that they found that higher pretreatment contemplation scores predicted outcome rather than early symptom change. Until more studies examine the predictive utility of the SOCS, it is difficult to say whether the identification of contemplation scores, as opposed to action scores, as a predictor reflects developmental differences in the way readiness to change influences treatment response. Nonetheless, what is consistent about these findings is that if clients are at least thinking about changing their behaviors, they are more likely to achieve successful outcomes.
Contrary to our expectations, higher precontemplation subscale scores predicted lower BDI scores at termination. There is no literature to support the direction of this finding, as high pretreatment precontemplation scores are typically associated with treatment dropout. However, we suspect therapists in our clinic identified clients with high scores on the precontemplation subscale at intake consistent with the mission of the training clinic. If indeed therapists were aware of this prognostic indicator and tailored treatment accordingly by supplementing CBT with motivational interviewing (MI; Miller, & Rollnick, 2002) , it is possible that clients who were initially at risk for dropping out received a supplemental intervention that improved their response. Unfortunately, our interpretation remains speculative, as we do not have the data to test this meditational analysis.
A more widely studied phenomenon is that of medication's effect on rate of depressive symptom improvement. Indeed, one of the desirable features of antidepressants is that they are fast acting, typically more so than psychotherapies (e.g., Keller et al., 2000) . The data presented here are no exceptionconcomitant psychotropic usage was significantly associated with an accelerated rate of change. Although the timing of medication commencement was not available in the present study, this finding is in line with Thase et al.'s (2007) study that showed randomizing patients to either cognitive therapy or pharmacologic approaches were comparable immediately after an unsuccessful antidepressant trial. 
Methodological Implications
These results, along with Gilboa-Schechtman and Shahar's (2006) and Santor and Segal's (2001) work, highlight the importance of simultaneously examining rates of symptom change and pretreatment variables. Investigating pretreatment factors separate from growth rates, or vice versa, may be misleading. Our findings suggest two methodological recommendations: (1) clinicians are encouraged to collect session-by-session symptom data, and (2) researchers may want to simultaneously include both sets of factors when investigating predictors of outcome.
Clinical Implications
Pretreatment predictors have long been the focus of treatment outcome research to identify prognostic indicators to aid in therapist treatment planning. However, few predictors of CBT have been consistently identified (Hamilton & Dobson, 2002) , making it difficult for the therapist to make sense of the large body of literature. The present study provides additional information, suggesting that rates of early symptom change may be an especially important indicator of successful treatment outcome. We are not suggesting that clients who do not demonstrate rapid early symptom change will be unsuccessful in CBT. Rather, predictors of early symptom change might serve as a guide for treatment planning. For instance, higher contemplation SOCS scores predicted an accelerated decline in depressive symptom severity. Therefore, in order to facilitate rapid early symptom change, interventions such as MI that prepare people for change might be important for the therapist to employ early in treatment. Also important to note is that hopefulness, which has been hypothesized to predict rapid early response, did not predict rate of symptom change or outcome when examined alongside readiness to change variables. As this line of research grows, concurrent examination of multiple potential predictors of early symptom change will be important.
The findings that comorbidity did not predict trajectories of early symptom change or outcome are important when thinking about the clinical implications of this work. There is literature to suggest that community therapists disregard empirically supported treatments (ESTs) because the efficacy tradition excluded clients with comorbidities (e.g., Addis, Wade, & Hatgis, 1999) . However, the results from the present study replicate a burgeoning literature that suggests comorbidity does not predict treatment outcome (e.g., Joormann, Kosfelder, & Schulte, 2005) . Rather, research suggests that the effect of comorbidity may be minimal, whereas the competence of the clinician may instead predict treatment outcome (Kuyken & Tsivrikos, 2009) . Indeed, in a separate article looking at the current study data, we identified therapist level of training as a predictor of early anxiety symptom change demonstrating incremental predictive utility when examined alongside comorbidity (Lewis, Kim, & Simons, 2010) . This finding might be due to the therapist's degree of comfort and familiarity with a more diverse set of CBT protocols. Therapists in our training clinic are exposed first to CBT for depression, and then the introduction of disorderspecific protocols (e.g., posttraumatic stress disorder, social phobia, generalized anxiety disorder) occurs based upon their caseload. Therefore, more advanced therapists were likely more proficient in applying anxiety-specific interventions, leading to rapid early symptom change. This could be important when considering efforts to disseminate CBT to community settings. Specifically, the proliferation of CBT protocols targeting multiple disorders has been important, but this means that clinicians are faced with learning numerous protocols with limited time.
Limitations
There are several noteworthy limitations. First, although we were able to examine the role of therapist level of training, it is unclear what this is actually measuring other than simply months in practicum. A more informative construct would be therapist competence. Relatedly, our study lacks the data to elaborate on treatment fidelity, and we did not control for general therapist effects. Unfortunately, we do not have data to support the claim that the therapists were indeed delivering CBT. Fidelity and competency ratings are thus both a limitation and a future direction of ours.
Second, for a number of reasons, the generalizability of this study may be somewhat limited. Specifically, clients with acute suicidality, psychosis, and concurrent substance dependence were referred out for more appropriate services. Similarly, the average symptom severity of the sample was moderate, suggesting few cases of severe nonpsychotic depression were represented in this sample. Further, the homogenous nature of the clients in terms of ethnicity and culture limits the generalizability.
Third, it is important to highlight the findings of this naturalistic study were not evaluated against a comparison or control condition. Therefore, we cannot conclude that the rapid early symptom change was a result of CBT per se or whether this finding would have emerged had a different therapy been provided or had we simply monitored the natural course of symptom change observed in a waitlist control. These comparisons will be important for future studies to examine in order to speak to the specificity of the findings reported here. In addition, as this was a naturalistic study, several of the clients entered treatment concurrently on a psychotropic medication. Unfortunately, we did not track use of psychotropic medication over the course of treatment. It is therefore a limitation of this study that we cannot clearly indicate the role of medication in the findings reported here. Finally, given our reliance on self-report data for the analyses, there is the possibility that shared method variance is at play, and therefore we encourage the results to be interpreted with caution.
Future Directions
There are numerous potential avenues for future research. First, although the present study collected data on session-by-session symptom severity, it would be important to collect data on potential mechanisms of change. Because of the robust nature of the predictive utility of the rapid rate of response, researchers have engaged in a debate over whether it is general therapy factors (working alliance; Ilardi & Craighead, 1994) or therapy specific factors (cognitive distortions; Tang & DeRubeis, 1999) at work. Until additional studies concurrently examine potential mechanisms of change, this debate will remain unresolved.
Second, this study has the data to speak to an important discussion emerging in the psychotherapy outcome field-a discussion that began with the reported observation that psychotherapy patients in the community attend, on average, only three sessions.
There is concern that this means that patients are receiving inadequate doses of psychotherapy; RCTs suggest between 10 and 20 sessions for a typical CBT protocol to achieve response. However, Baldwin, Berkeljon, Atkins, Olsen, and Nielsen (2009) recently found support for the "good enough level" of interpreting doseresponse relationships, suggesting that patients remain in therapy until they are better and that different doses are necessary to achieve response for different individuals. The findings reported here might also provide support for the idea of stepped care whereby more intensive interventions are provided for a subsample of individuals. A unique version of stepped care guided by the current study would suggest perhaps starting all clients with a formal, comprehensive assessment followed by brief interventions during which symptom change is closely monitored. Re-evaluation after the fifth session could guide intervention decisions by identifying those who did not rapidly respond to treatment to continue with intensive specialized psychotherapy protocols, whereas individuals demonstrating rapid early symptom change could go on to less intensive versions of continued treatment (e.g., computerized CBT, self-help books). However, future research systematically evaluating this approach is a necessary next step.
Conclusion
In conclusion, the present study sought to examine the incremental utility of multiple relevant psychotherapy factors, including pretreatment client variables and rate of early symptom change, through the merging of two different methodological approaches. Results indicate that the rates of depressive symptom change over the first five treatment sessions predicted outcome over and above the majority of pretreatment variables. Pretreatment predictors of rate of early symptom change-such as a contemplative orientation to change-were identified, which may suggest that therapists should target these factors to potentially maximize rapid early symptom change and, in turn, outcome.
